The 16 – 2 vote came after a sharp debate in which many of the panel’s independent experts, including infectious disease doctors and statisticians, challenged whether the data justified a broad rollout of extra shots when the vaccines appear to still offer robust protection against severe COVID-19 disease and hospitalization. The issue of whether or not to approve boosters has become increasingly contentious, dividing scientists, both outside and inside the FDA, including two scientists who recently announced they are leaving the agency because of pressure from the Biden administration to approve boosters, citing the lack of data to support a third shot. “It’s a welcome sight to see actual deliberations in meetings about vaccine booster shots at the FDA,” said Mary Holland, president of Children’s Health Defense. “It’s encouraging that a panel of experts stood up to political and corporate pressure based on the lack of convincing data for safety and efficacy of boosters.” https://childrenshealthdefense.org/defender/fda-panel-rejects-pfizer-booster-16-older
If You Find EarthNewspaper.com Informative, Please Make A Contribution Donate today and support the work I do seven days a week. Each day I publish more than a dozen news articles and videos, from honest, independent and reliable sources, on a completely ad-free website. There are four ways you may donate: credit card, check, bank wire, or SubscriberStar. I, Mark R. Elsis, thank you in advance for your gracious generosity, so that EarthNewspaper.com All The Honest News Fit To Publish may keep growing quickly. https://earthnewspaper.com/donate
